Successful Radical Resection Of Masaoka Iii Squamous Cell Thymic Carcinoma Invading Superior Vena Cava And Right Atrium – Case Report

Authors

  • Ágata Nawojowska Thoracic Surgery Department, Pulido Valente Hospital, CHULN, Lisbon, Portugal
  • Daniel Cabral Thoracic Surgery Department, Pulido Valente Hospital, CHULN, Lisbon, Portugal https://orcid.org/0000-0002-2891-5806
  • José Neves Cardiac Surgery Department, Santa Cruz Hospital, CHLO, Carnaxide, Portugal
  • Francisco Félix Thoracic Surgery Department, Pulido Valente Hospital, CHULN, Lisbon, Portugal

DOI:

https://doi.org/10.48729/pjctvs.456

Keywords:

case report, invasive thymic squamous cell carcinoma, intraauricular mass, cardiopulmonary bypass support, superior vena cava resection

Abstract

Introduction: Complete radical resection is crucial for successfully treating thymic carcinomas. However, when the invasion of the great vessels or the heart in Masaoka III and IV stages occurs, the management poses more challenges. The R0 resection often requires neoadjuvant treatment. We present an example of a debatable case in which a treatment decision was guided by an imminent risk to the patient's life.
Case description: We report the case of a 74-year-old female with a mediastinal mass invading the superior vena cava (SVC) and the right atrium (RA), which was successfully treated with radical resection. The procedure under the femoro-femoral CardioPulmonary Bypass (CPB) included resection of the right intra-auricular mass and the SVC followed by the interposition of a Gore-Tex conduit between the left innominate vein and RA and also wedge resection of the upper left (LUL) and right lobes (RUL). A final histopathological examination confirmed the diagnosis of squamous cell carcinoma.
Conclusions: Complete radical resection is essential for successful treatment and represents the most significant prognostic factor.

Downloads

Download data is not yet available.

References

Yang X, Zhao K, Li C, Yang Y, Guo C, Pu Y, Liu L. Thymic Squamous Cell Carcinoma: A Population-Based Surveillance, Epidemiology, and End Result Analysis. Front Oncol. 2020 Dec 22;10:592023. doi: 10.3389/fonc.2020.592023. PMID: 33415074; PMCID: PMC7783386.

Wu J, Wang Z, Jing C, Hu Y, Yang B, Hu Y. The incidence and prognosis of thymic squamous cell carcinoma: A Surveillance, Epidemiology, and End Results Program population-based study. Medicine (Baltimore). 2021 Apr 16;100(15):e25331 . doi: 10.1097/MD.0000000000025331. PMID: 33847631; PMCID: PMC8052076.

Sun Y, Liu J, Yu X. Treatment and prognosis of Masaoka stage 3 thymic carcinoma: a retrospective study of 32 cases. Onco Targets Ther. 2015 Apr 6;8:699-702. doi: 10.2147/OTT.578791. PMID: 25897244; PMCID: PMC4396510.

Cameron D. Wright, MD; Extended Resections for Thymic Malignancies; J Thorac Oncol. 2010;5: S344–S347; SSN: 1556–0864/10/0510–0344.

Ried, M., Neu, R., Schalke, B. et al. Radical surgical resection of advanced thymoma and thymic carcinoma infiltrating the heart or great vessels with cardiopulmonary bypass support. J Cardiothorac Surg. 101; 137 (2015). https://doi.org/10.1186/s13019-015-0346-2.

Downloads

Published

25-01-2025

How to Cite

1.
Nawojowska Ágata, Cabral D, Neves J, Félix F. Successful Radical Resection Of Masaoka Iii Squamous Cell Thymic Carcinoma Invading Superior Vena Cava And Right Atrium – Case Report. Rev Port Cir Cardiotorac Vasc [Internet]. 2025 Jan. 25 [cited 2025 Jan. 30];31(4):33-5. Available from: https://pjctvs.com/index.php/journal/article/view/456

Issue

Section

Clinical Cases

Categories

Most read articles by the same author(s)

<< < 1 2